Skip to main content
. Author manuscript; available in PMC: 2009 Mar 30.
Published in final edited form as: Eur J Neurosci. 2008 May;27(10):2493–2500. doi: 10.1111/j.1460-9568.2008.06250.x

Table 2.

Plasma levels of corticosterone in rats implanted either with a cholesterol or a 30% corticosterone pellet s.c., and infused i.c.v. with either BDNF or solvent

Treatment n Plasma corticosterone (ng/mL)
Saline (+RSA) i.c.v. + cholesterol s.c. 5 187.2 ± 36.5
Saline (+RSA) i.c.v. + corticosterone s.c. 9 141.0 ± 45.4
BDNF i.c.v. + cholesterol s.c. 5 132.4 ± 72.6
BDNF i.c.v. + corticosterone s.c. 8 130.0 ± 23.6

Data are presented as mean ± SD; n, number of animals in each group.

HHS Vulnerability Disclosure